Tarsus Pharmaceuticals TARS
NASDAQ TARS
$75.46 -3.15 (-4.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Shares Outstanding (Entity) (2019 - 2026)

Updated

Tarsus Pharmaceuticals' Shares Outstanding (Entity) came in at 43.27 million for Q2 2026, up 2.5% from 42.21 million a year earlier and up 0.6% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

For FY2025, Tarsus Pharmaceuticals' Shares Outstanding (Entity) was 42.55 million, up 11.0% from FY2024.

  • Shares Outstanding (Entity) has increased in each of the last six years, with a five-year compound annual growth rate of 47.0% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 38.35 million in FY2024 (+12.1%), 34.21 million in FY2023 (+28.0%), 26.73 million in FY2022 (+29.1%) and 20.7 million in FY2021 (+233.5%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2019.
  • Year-over-year, Shares Outstanding (Entity) has increased for 24 consecutive quarters, with growth averaging 9.6% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.9% (Q1 2022) to 613.8% (Q3 2021).
  • Business Quant data shows TARS's Shares Outstanding (Entity) at 43.02 million (Q1 2026), 42.55 million (Q4 2025) and 42.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn 43.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.27 Mn
Mar 31, 2026 43.02 Mn
Dec 31, 2025 42.55 Mn
Sep 30, 2025 42.45 Mn
Jun 30, 2025 42.21 Mn
Mar 31, 2025 42.00 Mn
Dec 31, 2024 38.35 Mn
Sep 30, 2024 38.20 Mn
Jun 30, 2024 38.03 Mn
Mar 31, 2024 37.75 Mn
Dec 31, 2023 34.21 Mn
Sep 30, 2023 33.10 Mn
Jun 30, 2023 26.90 Mn
Mar 31, 2023 26.80 Mn
Dec 31, 2022 26.73 Mn
Sep 30, 2022 26.70 Mn
Jun 30, 2022 26.64 Mn
Mar 31, 2022 20.72 Mn
Dec 31, 2021 20.70 Mn
Sep 30, 2021 20.70 Mn
API Access

Tarsus Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TARS&period=max&api_key=YOUR_API_KEY